Gema Biotech S.A.
GEMABIOTECH is a biotechnology company developing high-tech medicines for human health. It is a member of AMEGA Biotech, a biopharmaceutical platform that integrates development and production operations, designing all processes from clone selection to protein purification and finished product formulation. The company offers a complete line of first-generation biogenerics and a wide range of second-generation molecules, focusing on active pharmaceutical ingredients and finished products.
Industries
Nr. of Employees
large (251-1000)
Products
Etanercept
Therapeutic recombinant protein (listed product).
Interferon Alfa-2a
Therapeutic recombinant protein (listed product).
Interferon Alfa-2b
Therapeutic recombinant protein (listed product).
Peg-Interferon Alfa-2b
Therapeutic recombinant protein (PEGylated interferon) (listed product).
Interferon Beta-1a
Therapeutic recombinant protein (listed product).
Interferon Beta-1b
Therapeutic recombinant protein (listed product).
Etanercept
Therapeutic recombinant protein (listed product).
Interferon Alfa-2a
Therapeutic recombinant protein (listed product).
Interferon Alfa-2b
Therapeutic recombinant protein (listed product).
Peg-Interferon Alfa-2b
Therapeutic recombinant protein (PEGylated interferon) (listed product).
Interferon Beta-1a
Therapeutic recombinant protein (listed product).
Interferon Beta-1b
Therapeutic recombinant protein (listed product).
Services
Platform service that integrates development and production activities, offering workflows from clone selection through purified protein and finished product formulation on-site.
Platform service that integrates development and production activities, offering workflows from clone selection through purified protein and finished product formulation on-site.
Expertise Areas
- End-to-end biologics development and production
- Biogeneric / biosimilar development
- Cell line and clone development
- Upstream and downstream bioprocessing
Key Technologies
- Cell culture-based protein expression
- Chromatography and downstream purification methods
- Formulation development for biologics
- Bioprocess scale-up and manufacturing